The DOI matches its Crossref record.
HIV-1 subtypes: epidemiology and significance for HIV management
Abstract
PURPOSE OF REVIEW: This review presents an update on the molecular epidemic patterns of HIV-1 infection and the effects of subtype-related genetic variability on transmission, disease progression, response to antiretroviral therapy and drug-resistance pathways. RECENT FINDINGS: The molecular epidemiology of HIV-1 infection is complex and evolving. The emergence of new variants reflects HIV-1 prevalence, subtype epidemiology and risk-behaviour patterns in different geographical areas. Evidence indicates that certain subtypes may have a transmission advantage while others display higher replicative efficiency. The molecular mechanisms underlying these differences are being identified and include both virus- and host-related factors. Although drug susceptibility varies and clinical evidence remains limited, current antiretroviral regimens appear to have comparable efficacy in patients infected with B and non-B subtypes. Subtype-related variability influences resistance pathways. However, the major treatment-associated resistance mutations seen in subtype B also confer resistance in non-B subtypes and vice versa. SUMMARY: Genetic differences among HIV-1 variants can influence the virus biological properties, susceptibility to existing and candidate antiretroviral drugs, and evolution of antiretroviral drug resistance. Further studies are required to define the impact of this variability on risk of transmission, disease outcomes, responses to antiretroviral therapy and resistance pathways. Meanwhile, plasma viral load and CD4 count remain the important predictors of disease outcome, regardless of the infecting subtype. Current antiretroviral regimens can be used reliably to treat patients with both B and non-B subtypes, and resistance interpretation algorithms provide adequate guidance. The limitations of current evidence should be acknowledged and instigate ongoing vigilance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gazzard, B., & on behalf of the BHIVA Treatment Guidelines Writing Group (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00636.x · Cited by 1,089
Predictors of disease progression in HIV infection: a review
Langford, S. E., Ananworanich, J., & Cooper, D. A. (2007) · AIDS Research and Therapy · doi:10.1186/1742-6405-4-11 · Cited by 337
Functional signatures of protective antiviral T‐cell immunity in human virus infections
Harari, A., Dutoit, V., Cellerai, C., Bart, P., Du Pasquier, R. A., & Pantaleo, G. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00395.x · Cited by 273
Mishra, R., & Singh, S. K. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4796-12.2013 · Cited by 74
“In total HIV-1 infections, clade C alone infects 56% patients (Geretti, 2006).”
BackgroundGenetic and Functional Characterization of the LTR of HIV-1 Subtypes A and C Circulating in India
Rodriguez, M. A., Shen, C., Ratner, D., Paranjape, R. S., Kulkarni, S. S., Chatterjee, R., & Gupta, P. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0152 · Cited by 29
Metadata
- Authors
- Geretti, A. M.
- Venue
- Current Opinion in Infectious Diseases
- Published
- 2006-02
- Volume
- 19
- Issue
- 1
- Pages
- 1-7
- ISSN
- 0951-7375 (ISSN-L)
- OpenAlex
- W2020461877
- Cited by
- 223
- References
- 0
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HIV-1 subtypes: epidemiology and significance for HIV management. https://app.cochat.ai/papers/10.1097/01.qco.0000200293.45532.68
- The paper
- Geretti, A. M. (2006). HIV-1 subtypes: epidemiology and significance for HIV management. Current Opinion in Infectious Diseases. https://doi.org/10.1097/01.qco.0000200293.45532.68
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.